JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:2553-2560, doi:10.1016/j.jacc.2006.07.066 (Published online 28 November 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.07.066v1
48/12/2553    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heeschen, C.
Right arrow Articles by Cooke, J. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Heeschen, C.
Right arrow Articles by Cooke, J. P.

PRECLINICAL STUDIES

Endothelial Progenitor Cells Participate in Nicotine-Mediated Angiogenesis

Christopher Heeschen, MD*,{dagger}, Edwin Chang, PhD*, Alexandra Aicher, PhD{dagger} and John P. Cooke, MD, PhD*,*

* Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California
{dagger} Molecular Cardiology, J.W. Goethe University, Frankfurt, Germany

Manuscript received February 24, 2006; revised manuscript received July 10, 2006, accepted July 24, 2006.

* Reprint requests and correspondence: Dr. John P. Cooke, Division of Cardiovascular Medicine, Stanford University School of Medicine, Falk Cardiovascular Research Center, 300 Pasteur Drive, Stanford, California 94305 (Email: john.cooke{at}stanford.edu).

OBJECTIVES: We aimed to determine the role of endothelial progenitor cells (EPCs) in cholinergic angiogenesis.

BACKGROUND: Recently, we provided evidence for a new angiogenic pathway mediated by endothelial nicotinic acetylcholine receptors (nAChR). Increasing evidence suggests that circulating EPCs also contribute to postnatal neovascularization by homing to sites of neovascularization, a process termed postnatal vasculogenesis. Therefore, we investigated whether nAChR activation increases mobilization and/or recruitment of EPCs to a site of angiogenesis.

METHODS: To identify EPCs from reservoirs both inside and outside of the bone marrow and to avoid the adverse effects of total body irradiation, we employed a murine parabiosis model with tie-2-LacZ FvB/N mice connected to wild-type FvB/N mice and induced unilateral hind limb ischemia in the wild-type animal.

RESULTS: Administration of nicotine increased capillary density in the ischemic hind limb, and increased soluble Kit ligand plasma levels. The effect of systemic administration was greater than that of local delivery of nicotine (45% vs. 76% increase in capillary density by comparison to vehicle control, intramuscular vs. oral administration of nicotine; p < 0.05). Ischemia-induced incorporation of EPC in the control group was rare, but was increased 5-fold by systemic administration of nicotine. Exposure to nicotine in vitro increased EPC count and EPC transmigration. Finally, systemic administration of nicotine increased EPC number in the bone marrow and spleen during hind limb ischemia.

CONCLUSIONS: Nicotine treatment increased the number of EPCs in the bone marrow and spleen, and increased their incorporation into the vasculature of ischemic tissue. Administration of nicotine increased markers of EPC mobilization. This study indicates that the known angiogenic effect of nicotine may be mediated in part by mobilization of precursor cells.

Abbreviations and Acronyms
  DMXB = 3-(2,4)-dimethoxybenzylidene anabaseine
  EPC = endothelial progenitor cell
  FITC = fluorescein isothiocyanate
  HUVEC = human umbilical vein endothelial cell
  nAChR = nicotinic acetylcholine receptor
  SDF = stem cell-derived factor
  VEGF = vascular endothelial growth factor




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. Heiss, N. Amabile, A. C. Lee, W. M. Real, S. F. Schick, D. Lao, M. L. Wong, S. Jahn, F. S. Angeli, P. Minasi, et al.
Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production.
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1760 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Celermajer and M. K.C. Ng
Where there's smoke...
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1772 - 1774.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Tang, J. Lu, J. P. Walterscheid, H.-H. Chen, D. A. Engler, T. Sawamura, P.-Y. Chang, H. J. Safi, C.-Y. Yang, and C.-H. Chen
Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1
J. Lipid Res., January 1, 2008; 49(1): 33 - 47.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello
Role of Inflammation in Atherosclerosis
J. Nucl. Med., November 1, 2007; 48(11): 1800 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Avogaro and G. P. Fadini
The Janus Face of Nicotinic Angiogenesis
J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2561 - 2563.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.